Reverse Transcriptase Inhibitors in HIV/AIDS Therapy

1. Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery
David K. Stammers, Jingshan Ren

2. Zidovudine, Lamivudine, and Abacavir
Monica Carten, Harold Kessler

3. Stavudine, Didanosine, and Zalcitabine
Gail Skowron, Sapna Chowdhry, Michael R. Stevens

4. Emtricitabine
Gail Skowron, Jeffrey Bratberg, Rudi Pauwels

5. Nucleotide Analogs
Craig J Hoesley

6. Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Nancy Shulman, Mark Winters

7. Pharmacokinetics of Reverse Transcriptase Inhibitors
Patrick Hoggard, Stephen Kewn, Saye Khoo, David Back

8. Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy
Bruce A. Cohen, Russell Bartt

9. Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy
William Lewis

10. Mitochondrial Toxicity and Lipodystrophy
Grace McComsey

11. Nevirapine
David Asmuth, Richard Pollard

12. Efavirenz
Graeme J. Moyle, Brian Conway

13. Delavirdine
Brian Conway

14. Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
F. Ramzi Asfour, Richard Haubrich

15. Vertical Transmission of HIV and Therapeutic Interventions
Susan Cu-Uvin, Arlene Bardeguez, Carla Chibwesha

16. New Reverse Transcriptase Inhibitors in Development
Rudi Pauwels

17. Antiretroviral Drugs for Millions
Allan Ronald, Elly Katabira, Merle Sande

DRM-restrictions

Printing: not available
Clipboard copying: not available

Keywords: MEDICAL / Public Health MED078000